Link: https://www.cancer.org/cancer/types/breast-cancer/about/types-of-breast-cancer/triple-negative.html
Description: WebJul 21, 2021 · 5-year relative survival rates for triple-negative breast cancer. These numbers are based on women diagnosed with TNBC between 2012 and 2018.
DA: 47 PA: 51 MOZ Rank: 96
Link: https://www.verywellhealth.com/triple-negative-breast-cancer-prognosis-4778440
Description: WebAug 8, 2023 · Overall, the five-year survival rate for triple-negative breast cancer is 77% compared to the five-year survival rate of 91% for breast cancer in general. Triple-negative breast cancer is also more likely to recur (come back) after treatment.
DA: 45 PA: 90 MOZ Rank: 1
Link: https://www.medicalnewstoday.com/articles/324272
Description: WebAug 25, 2023 · Triple-negative breast cancer can spread faster and is more likely to recur than other types of breast cancer. With early diagnosis, the 5-year survival rate is 91%, but rates are lower...
DA: 48 PA: 7 MOZ Rank: 77
Link: https://cancerblog.mayoclinic.org/2024/01/03/understanding-triple-negative-breast-cancer-and-its-treatment/
Description: WebJan 3, 2024 · Roberto Leon Ferre, M.D. Dr. Leon Ferre and other researchers at Mayo Clinic are working to understand how triple-negative breast cancer grows and spreads, how the immune system may recognize and fight it, and to develop new treatments for the disease. If you've been diagnosed with this breast cancer subtype, here’s what you should know:
DA: 44 PA: 56 MOZ Rank: 51
Link: https://my.clevelandclinic.org/health/diseases/21756-triple-negative-breast-cancer-tnbc
Description: WebMay 15, 2023 · What are survival rates for triple-negative breast cancer? According to the American Cancer Society, survival rates vary depending on cancer stage at diagnosis: Local or Stage 0–Stage 1 survival rate: More than 90% of …
DA: 74 PA: 54 MOZ Rank: 66
Link: https://www.cancer.gov/news-events/cancer-currents-blog/2022/pembrolizumab-triple-negative-breast-cancer-improves-survival
Description: WebAugust 9, 2022 , by Edward Winstead. Adding the immunotherapy drug pembrolizumab (Keytruda) to chemotherapy can help some patients with advanced triple-negative breast cancer live longer than if they received chemotherapy alone, new results from a …
DA: 36 PA: 24 MOZ Rank: 44
Link: https://www.cdc.gov/cancer/breast/triple-negative.htm
Description: WebPrint. View Transcript Low Resolution Video. This video introduces Talk to Someone: Triple-Negative Breast Cancer, an interactive conversation with the virtual triple-negative breast cancer survivor, Linda. What Is Triple-Negative Breast Cancer?
DA: 13 PA: 43 MOZ Rank: 15
Link: https://www.mdanderson.org/cancer-types/breast-cancer/triple-negative-breast-cancer.html
Description: WebEach individual with triple-negative breast cancer is unique and survival rates depend on several factors, including how far the cancer has spread at the time it is found and how the tumor responds to treatment. Overall, the five-year survival rate for …
DA: 78 PA: 5 MOZ Rank: 38
Link: https://cancerblog.mayoclinic.org/2024/04/25/new-study-finds-triple-negative-breast-cancer-tumors-with-an-increase-in-immune-cells-have-lower-risk-of-recurrence-after-surgery/
Description: WebApr 25, 2024 · By Kelley Luckstein. A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy. The study was published today in the …
DA: 42 PA: 55 MOZ Rank: 95
Link: https://www.cancer.org/cancer/types/breast-cancer/treatment/treatment-of-triple-negative.html
Description: WebJul 21, 2021 · an oral chemo drug called capecitabine (Xeloda) for 18 to 24 weeks. This might help some women live longer. more pembrolizumab after surgery (adjuvant treatment) to reduce the chances of the cancer coming back. the targeted drug olaparib for one year for women who have a BRCA mutation to help lower the chance of the cancer recurring.
DA: 58 PA: 57 MOZ Rank: 12
